ERG overexpression as the result of chromosomal translocations in prostate cancer correlates with malignancy and invasiveness, poor prognosis and shorter survival times.12 In these circumstances, ERG acts as an oncogene. This evidence concerns the gene ERG and Familial prostate cancer.